AgomAb Therapeutics NV AGMB
5.62 USD -0.20 (-3.44%)
Regular-session close
5.72 +0.10 +1.78%
After hours · Nov 19, 4:24 PM ET
5.59 Day range 6.00
5.50 52-week range 17.82
- YTD
- -61.64%
- 1 year
- -61.64%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| -59.27M | -48.02M | -31.19M | |
| -62.55M | -46.27M | -11.39M | |
| -6.60 | -4.95 | -1.65 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| 86.42M | 171.46M | 122.40M | |
| 153.71M | 206.36M | 171.26M | |
| 22.80M | 18.28M | 19.82M | |
| 1.25M | 1.54M | 1.62M | |
| 130.90M | 188.08M | 151.44M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| -51.74M | -46.83M | -24.59M | |
| -33.00M | -675.00K | 40.00M | |
| -338.00K | 96.76M | 79.32M | |
| -4.00K | -675.00K | 0 | |
| -85.08M | 49.26M | 94.73M |
